for the Period Ended 30 November 2023
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 30 November 2023
Principal activities of the company
Political and charitable donations
Additional information
Review of business and future developments The financial position of the Company at 30 November 2023 is considered to be satisfactory, and this is forecast to continue. Results and dividends The Company’s results for the year are shown on page 5. The result for the financial year is £4,750,000 profit (2022: £4,000,000 profit). The Company has paid a dividend in the year of £4,750,000 (2022: £4,000,000). The Directors do not recommend payment of a final dividend. Directors The Directors who were in office during the year and up to the date of signing the financial statements were as follows: B D W Stocks J A Mills Going concern The Directors have reviewed the cash flow forecast for the period ending 24 months from the balance sheet date. The forecast represents the Directors’ best estimate of the Company’s future performance, which is subject to inherent uncertainties. However, the forecast demonstrates that the Directors have a reasonable expectation that the Company will be able to meet its liabilities as they fall due, for a period of at least 12 months from the date of approval of these financial statements. Therefore, after due consideration of the risks and uncertainties associated with the business of the Company and, having made appropriate enquiries, the Directors have a reasonable expectation that the Company has adequate resources and has the ability to continue trading on normal terms of the business for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing these financial statements.
Directors
The directors shown below have held office during the whole of the period from
1 December 2022
to
30 November 2023
Secretary
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Secretary
for the Period Ended
2023 | 2022 | |
---|---|---|
|
£ |
£ |
Other operating income: |
|
|
Operating profit(or loss): |
|
|
Profit(or loss) before tax: |
|
|
Profit(or loss) for the financial year: |
|
|
As at
Notes | 2023 | 2022 | |
---|---|---|---|
|
£ |
£ |
|
Fixed assets | |||
Investments: | 3 |
|
|
Total fixed assets: |
|
|
|
Net current assets (liabilities): | |||
Total assets less current liabilities: |
|
|
|
Creditors: amounts falling due after more than one year: | 4 |
(
|
(
|
Total net assets (liabilities): |
|
|
|
Capital and reserves | |||
Called up share capital: |
|
|
|
Other reserves: |
|
|
|
Profit and loss account: |
|
|
|
Total Shareholders' funds: |
|
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 November 2023
Basis of measurement and preparation
Other accounting policies
for the Period Ended 30 November 2023
2023 | 2022 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 30 November 2023
Fixed asset investments Shares in subsidiary undertakings: Cost at 30 November 2022 and 30 November 2023 £23,997,000 The Company has the following subsidiary undertakings: Porvair Sciences Limited Design and manufacture of filter based disposables and instrumentation for use in the biotechnology market England and Wales 100% Porvair Filtration Group Limited Sale and manufacture of porous metal and plastic materials, specialist filtration and microfiltration products and filters England and Wales 100% Microfiltrex Limited Dormant England and Wales 100% * * shares owned by Porvair Filtration Group Limited All the companies listed above are registered at 7 Regis Place, Bergen Way, King’s Lynn, PE30 2JN, UK. The Directors believe that the carrying value of the investments is supported by their underlying net assets.
for the Period Ended 30 November 2023
2023 | 2022 | |
---|---|---|
£ | £ | |
Other creditors |
|
|
Total |
|
|